Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookGuidelines for Antiretroviral Therapy in Ghana (MOH-GHS; 2002; 40 pages)
View the documentACKNOWLEDGEMENTS
View the documentFOREWORD
View the documentLIST OF ACRONYMS
Open this folder and view contentsCHAPTER 1
Open this folder and view contentsCHAPTER 2
Open this folder and view contentsCHAPTER 3
Open this folder and view contentsCHAPTER 4
View the documentAPPENDIX 1
View the documentAPPENDIX 2
View the documentAPPENDIX 3
View the documentAPPENDIX 4
 

APPENDIX 2

WHO CLINICAL STAGING SYSTEM FOR HIV INFECTION AND DISEASE

Patients with HIV infection who are aged 13 years or older are clinically staged on the basis of the presence of the clinical condition, or performance score, belonging to the highest level. (this staging differs from that used for AIDS surveillance)

CLINICAL STAGE 1

• Asymptomatic
• Generalised lymphadenopathy,
• Perfomance scale 1: asymptomatic, normal activity


CLINICAL STAGE 2

• Weight loss < 10% body weight (and > 5%)

• Minor mucocutaneous manifestations (seborrheic dermatitis: prurigo, fungal nail infections, recurrent oral ulcerations, angular stomatitis)

• Herpes Zoster within the last 5 years

• Recurrent upper respiratory tract infections (i.e. bacterial sinusitis)

• And/or performance scale 2: symptomatic, normal activity


CLINICAL STAGE 3

• Weight loss > 10% body weight
• Unexplained chronic diarrhoea > 1 month
• Unexplained prolonged fever (intermittent or constant) > 1 month
• Oral candidiasis
• Oral hairy leukoplakia
• Pulmonary tuberculosis within the previous year
• Severe bacterial infections(ie. Pneumonia, pyomyositis)
• And/or performance scale 3: bed-ridden < 50% of the day during the last month


CLINICAL STAGE 4

• HIV wasting syndrome (as defined by CDC (i.e weight loss > 10% body weight, plus either unexplained chronic diarrhoea (. 1 month), or chronic weakness and unexplained prolonged fever (> 1 month))

Pneunmocysitis carinii pneumonia

• Toxoplasmosis of the brain

• Cryptosporidiosis with diarrhoea > 1 month

• Cryptococcus (extrapulmonary)

• Cytomegalovirus of an organ other than the liver, spleen or lymph nodes

• Herpes simplex virus infection, mucocutaneous > 1 month, or visceral any duration

• Progressive multifocal leukoencephalopathy

• Any disseminated endemic mycosis

• Candidiasis of the oesophagus, trachea, bronchi or lungs

• Atypical mycobacteriosis, disseminated

• Non-typhoidal salmonella septicaemia

• Extrapulmonary tuberculosis

• Lymphoma

• Kaposi's sarcoma

• HIV encephalopathy (as defined by CDC)

• And/or performance scale 4: bed-ridden > 50% of the day during last month


LABORATORY STAGE

CLINICAL STAGE OF DISEASE (1-4)

 

Total lymphocyte count x 106/I

CD4+

Asymptomatic

Early

Intermediate

Late

A

>2000.

>500

1A

2A

3A

4A

B

1000-2000

200 -500

1B

2B

3B

4B

C

<1000

<200

1C

2C

3C

4C

to previous sectionto next section

Please provide your feedback English  |  French